Heart rate variability in chronic Chagas patients before and after treatment with benznidazole

Autonomic Neuroscience: Basic and Clinical

Volumn 158, Issue 1-2, 2010, Pages 118-122

  Oliveira, Lívia F A ^a   Silva, Valdo J D ^a   Lages Silva, Eliane ^a   Molina, Rodrigo J ^a   Fuzissaki, Juliano ^a   Niederhaur, Saulo ^a   Prata, A ^a   Correia, Dalmo ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Benznidazole; Chagas disease; Heart rate variability; Treatment

Indexed keywords

BENZNIDAZOLE;

ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; COLD FACE TEST; CONTROLLED STUDY; FEMALE; FUNCTION TEST; GENOTYPE; HEART RATE VARIABILITY; HUMAN; MALE; PRIORITY JOURNAL; TACHYCARDIA; TILT TEST; TRYPANOSOMA CRUZI;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; AUTONOMIC NERVOUS SYSTEM DISEASES; CHAGAS DISEASE; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NITROIMIDAZOLES; TRYPANOCIDAL AGENTS; YOUNG ADULT;

EID: 78149409997     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.05.004     Document Type: Article

References (29)

1. Amorim D.S., Marin-Neto J.A. Functional alterations of the autonomic nervous system in Chagas' heart disease. São Paulo Med. J. 1995, 113(2):772-784.
2. Avila H.A., Sigman D.S., Cohen L.M., Millikan R.C., Simpson L. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas disease. Mol. Biochem. Parasitol. 1991, 48(2):211-221.
3. Borda E.S., Sterin-Borda L. Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy. Int. J. Cardiol. 1996, 54(2):149-156.
4. Britto C., Silveira C., Cardoso M.A., Marques P., Luquetti A., Macêdo V., Fernandes O. Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction. Mem. Inst. Oswaldo Cruz 2001, 96(6):823-826.
5. Chagas C. Nova tripanosomíase humana. Imp. Med. 1909, 17:154-155.
6. Chagas C., Villela E. Forma cardiaca de Trypanosomiase Americana. Mem. Inst. Oswaldo Cruz 1922, 14(1):5-61.
7. Correia D., Junqueira L.F., Molina R.J., Prata A. Cardiac autonomic modulation evaluated by heart interval variability is unaltered but subtly widespread in the indeterminate Chagas' disease. Pace 2007, 30(6):772-780.
8. Dutra W.O., Gollob K.J. Current concepts in immunoregulation pathology of human Chagas disease. Curr. Opin. Infect. Dis. 2008, 2193:287-292.
9. Flores-Vieira C.L.L., Chimelli L., Fernandes R.M.F., Barreira A.A. Experimental benznidazole encephalopathy: II. Electroencephalographic and morphological alterations. J. Neurol. Sci. 1997, 150(1):13-25.
10. Hyland K.V., Leon J.S., Daniels M.D., Giafis N., Woods L.M., Bahk T.J., Wang K., Engman D.M. Modulation of autoimmunity by treatment of an infectious disease. Infect. Immun. 2007, 75(7):3641-3650.
11. Junqueira L.F., Soares J.D. Impaired autonomic control of heart interval changes to Valsalva maneuver in Chagas' disease without over manifestation. Auton. Neurosci. 2002, 97:59-67.
12. Junqueira A.C.V., Chiari E., Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of North-Eastern Brazil. Trans. R. Soc. Trop. Med. Hyg. 1996, 90(2):129-132.
13. Kirchhoff L.V., Votava J.R., Ochs D.E., Moser D.V. Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J. Clin. Microbiol. 1996, 34(5):1171-1175.
14. Köberle F. Pathology and pathological anatomy of Chagas' disease. Bol. Oficina Sanit. Panam. 1961, 51:404-428.
15. Macedo A.M., Martins M.S., Chiari E., Pena S.D. DNA fingerprinting of Trypanosoma cruzi: a new tool for characterization of strains and clones. Mol. Biochem. Parasitol. 1992, 55(1-2):147-153.
16. Marin-Neto J.A., Bromberg-Marin G., Pazin-Filho A., Simões M.V., Maciel B.C. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int. J. Cardiol. 1998, 65(3):261-269.
17. Marin-Neto J., Cunha-Neto E., Maciel B.C., Simões M.V. Pathogenesis of chronic Chagas heart disease. Circulation 2007, 115(9):1109-1123.
18. Molina R.B.G., Matsubara B.B., Hueb J.C., Zanati S.G., Meira D.A., Cassolato J.L., Paiva S.A., Zornoff L.A. Dysautonomia and ventricular dysfunction in the indeterminate from of Chagas disease. Int. J. Cardiol. 2006, 113(2):188-193.
19. Moncayo A., Ortiz-Yanine M.I. An update on Chagas disease (human American trypanosomiasis). Ann. Trop. Med. Parasitol. 2006, 100(8):63-77.
20. Montano N., Ruscone T.G., Porta A., Lombardi F., Pagani M., Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994, 90(4):1826-1831.
21. Morel C., Chiari E., Camargo E.P., Mattei D.M., Romanha A.J., Simpson L. Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc. Natl. Acad. Sci. U. S. A. 1980, 77(11):6810-6814.
22. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet 2001, 1(2):92-100.
23. Resende L.A.P.R., Molina R.J., Ferreira B.D.C., Carneiro A.C., Ferreira L.A., Silva V.J., Prata A., Correia D. Cardiac autonomic function in chagasic elderly patients in an endemic area: a time and frequency domain analysis approach. Auton. Neurosci. 2007, 131(1-2):94-101.
24. Ribeiro A.L., Lombardi F., Sousa M.R., Barros M.L.V., Porta A., Barros V.C.V., Gomes M.E.D., Machado F.S., Rocha M.O.C. Power-law behavior of heart rate variability in Chagas' disease. Am. J. Cardiol. 2002, 89(4):414-418.
25. Russomando G., de Tomassone M.M., de Guillen I., Costa N., Vera N., Almiron M., Candia N., Calcena M.F., Figueredo A. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am. J. Trop. Med. Hyg. 1998, 59(3):487-491.
26. Stemper B., Hilz M.J., Rauhut U., Neundorfer B. Evaluation of cold face test bradycardia by means of spectral analysis. Clin. Auton. Res. 2002, 12(2):78-83.
27. Tarleton R.L., Zhang L. Chagas disease ethiology: autoimmunity or parasite persistence?. Parasitol. Today 1999, 15(3):94-99.
28. Toledo M.J., Bahia M.T., Carneiro C.M., Martins-Filho O.A., Tibayrenc M., Barnabe C., Tafuri W.L., Lana M. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrob. Agents Chemother. 2003, 47(1):223-230.
29. Vianna G. Contribuição para o estudo da anatomia patológica da moléstia de Chagas (Esquizotripanose humana ou tireoidite parasitária). Mem. Inst. Oswaldo Cruz 1911, 3(2):276-283.